Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials-Reference-Cited by-同舟云学术

Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials

Published:2021-01 Issue: Volume:167 Page:1030-1047
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Hosseini Seyed Samad,Khalili Saeed,Baradaran Behzad,Bidar Negar,Shahbazi Mohammad-Ali,Mosafer Jafar,Hashemzaei Mahmoud,Mokhtarzadeh Ahad,Hamblin Michael R.

Funder

Tabriz University of Medical Sciences

Academy of Finland

NIH

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference160 articles.

1. X. Yan, Y. Zhao, Y. Zhang, H. Qu, Monoclonal antibodies and immunoassay for medical plant-derived natural products: a review, Molecules. 22 (2017). doi:https://doi.org/10.3390/molecules22030355.

2. Monoclonal antibodies in oncology therapeutics: present and future indications;Bhutani;Expert. Opin. Biol. Ther.,2013

3. An innovative immunosensor for ultrasensitive detection of breast cancer specific carbohydrate (CA 15-3) in unprocessed human plasma and MCF-7 breast cancer cell lysates using gold nanospear electrochemically assembled onto thiolated graphene quantum dots;Hasanzadeh;Int. J. Biol. Macromol.,2018

4. Immunosensing of breast cancer prognostic marker in adenocarcinoma cell lysates and unprocessed human plasma samples using gold nanostructure coated on organic substrate;Hasanzadeh;Int. J. Biol. Macromol.,2018

5. Targeted cancer therapy through antibody fragments-decorated nanomedicines;Alibakhshi;J. Control. Release,2017

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody;Immunobiology;2024-11

2. A novel bispecific peptide targeting PD-1 and PD-L1 with combined antitumor activity of T-cells derived from the patients with TSCC;International Immunopharmacology;2024-09

3. Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome;Immunology;2024-08-02

4. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28

5. HER3 receptor and its role in the therapeutic management of metastatic breast cancer;Journal of Translational Medicine;2024-07-17